Stone X Group Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Stone X Group Inc.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$595.12 - $698.43 $224,360 - $263,308	-377 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$543.48 - $670.97 $56,521 - $69,780	-104 Reduced 21.62%	377 $238,000
Q3 2021 Oct 20, 2021	SELL	$574.03 - $680.96 $3,444 - $4,085	-6 Reduced 1.23%	481 $291,000
Q2 2021 Aug 06, 2021	BUY	$472.8 - $558.54 $4,728 - $5,585	10 Added 2.1%	487 $272,000
Q1 2021 Jun 23, 2021	SELL	$446.73 - $548.2 $14,295 - $17,542	-32 Reduced 6.29%	477 $225,000
Q4 2020 Feb 03, 2021	BUY	$478.3 - $607.98 $2,391 - $3,039	5 Added 0.99%	509 $245,000
Q3 2020 Nov 12, 2020	BUY	$544.75 - $658.21 $12,529 - $15,138	23 Added 4.78%	504 $282,000
Q2 2020 Aug 12, 2020	SELL	$493.32 - $643.92 $14,799 - $19,317	-30 Reduced 5.87%	481 $299,000
Q1 2020 Apr 30, 2020	BUY	$336.18 - $494.43 $171,787 - $252,653	511 New	511 $249,000
Q3 2018 Oct 03, 2018	SELL	$351.14 - $408.51 $236,668 - $275,335	-674 Closed	0 $0
Q2 2018 Jul 23, 2018	BUY	$284.6 - $344.99 $191,820 - $232,523	674 New	674 $233,000
Q3 2017 Nov 13, 2017	SELL	$431.38 - $504.0 $303,691 - $354,816	-704 Closed	0 $0
Q2 2017 Aug 31, 2017	BUY	N/A	704	704 $346,000

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Stone X Group Inc., based on Form 13F filings with the SEC.

Stay updated on Stone X Group Inc. with notifications on news.